MoonLake Immunotherapeutics MLTX Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's accrued manufacturing costs?
- MoonLake Immunotherapeutics (MLTX) reported accrued manufacturing costs of $2.2M in Q1 2026.
- How has MoonLake Immunotherapeutics's accrued manufacturing costs changed year-over-year?
- MoonLake Immunotherapeutics's accrued manufacturing costs decreased by 13.5% year-over-year, from $2.54M to $2.2M.
- What is the long-term trend for MoonLake Immunotherapeutics's accrued manufacturing costs?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's accrued manufacturing costs has grown at a 13.1% compound annual growth rate (CAGR), from $1.42M to $2.32M.